Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aldo-keto reductase family member C20 (AKR1C20)
- Target
- AKR1C20
- Molecular classification
- Enzyme, Aldo-Keto Reductases
01
Overview
AKR1C20 is an aldo-keto reductase enzyme involved in the reduction of aldehydes and ketones. It participates in the metabolism of glycosides, progesterone, and prostaglandins. Its activity is linked to oxidoreductase and geranylgeranyl reductase functions.
- Other names
- 2610528B18Rik
02
Mechanism of action
Catalyzes reduction of aldehydes and ketones to alcohols using NADH or NADPH as cofactors.
03
Biological functions
Glycoside metabolic processProgesterone metabolic processProstaglandin metabolic processOxidoreductase activityGeranylgeranyl reductase activity
Beyond the preview
Go deeper on Aldo-keto reductase family member C20 (AKR1C20).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aldo-keto reductase family member C20 (AKR1C20).